Targeted Adenoviral Vectors I: Transductional Targeting

Igor P. Dmitriev, Sergey A. Kaliberov

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Scopus citations

Abstract

Human adenovirus (Ad) has been used extensively to develop gene transfer vectors for vaccine and gene therapy applications. A major factor limiting the efficacy of the current generation of Ad vectors is their inability to accomplish specific gene delivery to the cells of interest. Transductional targeting strategies seek to redirect virus binding to the appropriate cellular receptor to increase infection efficiency in selected cell types to achieve therapeutic intervention. These efforts mainly focused on incorporating targeting ligands by means of chemical conjugation or genetic modification of Ad capsid proteins and using bispecific adapter molecules to mediate virus recognition of target cells. This review summarizes current progress in Ad tropism modification maneuvers that embody genetic capsid modification and adapter-based approaches that have encouraging implications for further development of advanced vectors suitable for clinical translation.

Original languageEnglish
Title of host publicationAdenoviral Vectors for Gene Therapy
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages231-257
Number of pages27
ISBN (Print)9780128002766
DOIs
StatePublished - Apr 6 2016

Keywords

  • Adapter-mediated
  • Adenovirus
  • Gene therapy
  • Gene transfer
  • Genetic
  • Receptor-specific
  • Targeting
  • Transduction
  • Vector

Fingerprint

Dive into the research topics of 'Targeted Adenoviral Vectors I: Transductional Targeting'. Together they form a unique fingerprint.

Cite this